reports
Bekaert achieves ISCC PLUS certification for steel tire reinforcement,...
Bekaert achieves ISCC PLUS certification for steel tire reinforcement, pioneering certified materials in the tire industry Bekaert achieves ISCC PLUS certification for steel tire reinforcement, pioneering certified materials in the tire industry Bekaert has received ISCC PLUS certification for its steel tire reinforcement products. This milestone underscores Bekaert’s commitment to sustainability, innovation, and collaboration with tire manufacturers to accelerate the adoption of high recycled content tire reinforcement materials. From Bekaert standard to global recognition The Bekaert...
Bekaert bevestigt zijn voortrekkersrol in de bandenindustrie met ISCC ...
Bekaert bevestigt zijn voortrekkersrol in de bandenindustrie met ISCC PLUS-certificering voor staalkoord voor bandenversterking Bekaert bevestigt zijn voortrekkersrol in de bandenindustrie met ISCC PLUS-certificering voor staalkoord voor bandenversterking Bekaert heeft een ISCC PLUS-certificering gekregen voor zijn staalkoord voor bandenversterking. De mijlpaal benadrukt Bekaerts inzet voor duurzaamheid, innovatie en samenwerking met bandenfabrikanten om de transitie naar materialen met een hoog gerecycleerd gehalte voor bandenversterking te versnellen. De Bekaert Recycled Content ...
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 19 February 2026 to 25 February 2026 Share Buyback ProgramBekaert announced yesterday that it has completed the fifth tranche of its € 200 million share buyback program. During the tranche, which started 21 November 2025 and ended on 25 February 2026, the company repurchased 620 672 ordinary shares for an aggregate consideration of € 24.5 million. Bekaert announces today that during the period from 19 February 2026 to 25 February 2026, Kepler C...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquid...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 19 februari 2026 tot 25 februari 2026 Inkoopprogramma van Eigen AandelenGisteren kondigde Bekaert aan dat het de vijfde tranche heeft voltooid van het inkoopprogramma van eigen aandelen van € 200 miljoen. Tijdens deze tranche, die begon op 21 november 2025 en eindigde op 25 februari 2026, heeft het bedrijf 620 672 aandelen teruggekocht voor een totaalbedrag van € 24,5 miljoen. Bekaert kondigt vandaag aan da...
Inventiva to Participate in Four Upcoming March Investor Conferences
Inventiva to Participate in Four Upcoming March Investor Conferences Daix (France), New York (United States), February 26, 2026 – (Euronext Paris and NASDAQ: ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that the Company’s leadership will participate in one-on-one meetings and presentations during the following upcoming investor events: TD Cowen 46th Annual Health Care Conference – March 2-4, 2026Date: Monday, March 2,...
Inventiva participera à quatre conférences investisseurs en mars
Inventiva participera à quatre conférences investisseurs en mars Daix (France), New York (États-Unis), le 26 février 2026 – (Euronext Paris et Nasdaq : ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une thérapie orale pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), a annoncé aujourd’hui que la direction de la Société participera à des réunions individuelles et à des présentations lors des événements investisseurs suivants : TD Cowen 46ème Health Care Conference – 2 au 4 mars 2026Date : lun...
Inventiva to Participate in Four Upcoming March Investor Conferences
Inventiva to Participate in Four Upcoming March Investor Conferences Daix (France), New York (United States), February 26, 2026 – (Euronext Paris and NASDAQ: ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that the Company’s leadership will participate in one-on-one meetings and presentations during the following upcoming investor events: TD Cowen 46th Annual Health Care Conference – March 2-4, 2026Date: Monday, March 2,...
Inventiva to Participate in Four Upcoming March Investor Conferences
Inventiva to Participate in Four Upcoming March Investor Conferences Daix (France), New York (United States), February 26, 2026 – (Euronext Paris and NASDAQ: ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapie for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that the Company’s leadership will participate in one-on-one meetings and presentations during the following upcoming investor events: TD Cowen 46th Annual Health Care Conference – March 2-4, 2026Date: Monday, March 2...
- Oliver Metzger
BEKB BEKAERT SA
SOP SOPRA STERIA GROUP SA
NXI NEXITY SA CLASS A
SBMO SBM OFFSHORE NV
MF WENDEL SE
POM PLASTIC OMNIUM SE
ITP INTERPARFUMS
GXI GERRESHEIMER AG
FNAC FNAC DARTY SA
ATE ALTEN SA
EBRO EBRO FOODS SA
G24 SCOUT24 AG
GLB GLANBIA PLC
MTELEKOM MAGYAR TELEKOM TELECOMMUNICATIONS
SUN SULZER AG
VRNL VERNEUIL PARTICIPATIONS
AIXA AIXTRON SE
FTON FEINTOOL INTERNATIONAL HOLDING AG
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
RIEN RIETER HOLDING AG
EMMN EMMI AG
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
EDR EDREAMS ODIGEO SA
CON CONZZETA AG
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
CSM CORBION NV
WLN WORLDLINE SA
FNTN FREENET AG
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
TRP TERAPLAST
FTG111 FLATEXDEGIRO AG
HOME NEINOR HOMES SA
BFSA BEFESA SA
NFN NFON AG
GRE GRENERGY RENOVABLES
FQT FREQUENTIS AG WIENER
UPG UNIFIEDPOST GROUP
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
ALAFY AFYREN
DEME DEME GROUP NV
ADTN ADTRAN HOLDINGS INC
7V0 DARWIN AG
SHUR SHURGARD SELF STORAGE LIMITED
ACAG AUSTRIACARD HOLDINGS AG
PLNW PLANISWARE
CO CASINO GUICHARD-PERRACHON
4X0 STEYR MOTORS AG
- Oliver Metzger
BEKB BEKAERT SA
SOP SOPRA STERIA GROUP SA
NXI NEXITY SA CLASS A
SBMO SBM OFFSHORE NV
MF WENDEL SE
POM PLASTIC OMNIUM SE
ITP INTERPARFUMS
GXI GERRESHEIMER AG
FNAC FNAC DARTY SA
ATE ALTEN SA
EBRO EBRO FOODS SA
G24 SCOUT24 AG
GLB GLANBIA PLC
MTELEKOM MAGYAR TELEKOM TELECOMMUNICATIONS
SUN SULZER AG
VRNL VERNEUIL PARTICIPATIONS
AIXA AIXTRON SE
FTON FEINTOOL INTERNATIONAL HOLDING AG
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
RIEN RIETER HOLDING AG
EMMN EMMI AG
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
EDR EDREAMS ODIGEO SA
CON CONZZETA AG
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
CSM CORBION NV
WLN WORLDLINE SA
FNTN FREENET AG
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
TRP TERAPLAST
FTG111 FLATEXDEGIRO AG
HOME NEINOR HOMES SA
BFSA BEFESA SA
NFN NFON AG
GRE GRENERGY RENOVABLES
FQT FREQUENTIS AG WIENER
UPG UNIFIEDPOST GROUP
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
ALAFY AFYREN
CTPNV CTP NV
DEME DEME GROUP NV
ADTN ADTRAN HOLDINGS INC
7V0 DARWIN AG
SHUR SHURGARD SELF STORAGE LIMITED
ACAG AUSTRIACARD HOLDINGS AG
PLNW PLANISWARE
CO CASINO GUICHARD-PERRACHON
4X0 STEYR MOTORS AG
- ING Helpdesk
Benelux Morning Notes
Aalberts: In-line FY25, but low quality / AMG: 4Q25 beat by 7%; in-line 2026 guidance / Bekaert: In-line 2025, cautious outlook for 2026 to result in c.8% consensus cut / CMB.TECH: A small bit beat but not the full story / Corbion: Dividend sweetener / CTP: Q4 results lighter due to some delays; stronger 2026 outlook / DEME: Strong FY25 numbers and FY26 outlook / Elia Group: Preview FY25 results / SBM Offshore: Another step-up in shareholder return / Syensqo: Substantial miss in 4Q25; FY26 outlo...
- Martijn Den Drijver
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Livio Luyten
- Mathijs Geerts Danau
- Wim Hoste
- Wim Lewi
- Wim Hoste
Bekaert FIRST LOOK: FY25 results in line with expectations, cautious g...
FY25 uEBIT was in line with earlier guidance and our and consensus forecasts. The FY26 guidance of a flat uEBIT margin is more cautious than our (+0.4pp) and consensus (+0.5pp) forecasts. The healthy free cash flow generation and solid balance sheet allow Bekaert to work on both M&A and share buybacks, and the current share buyback pace (c. €100m/y) in combination with the dividend imply a yearly attractive return to shareholders of c. 9%. With valuation still attractive, we maintain our BUY rat...
Bekaert announces the next tranche of its Share Buyback Program
Bekaert announces the next tranche of its Share Buyback Program Bekaert announces the next tranche of its Share Buyback Program Bekaert announces that it will start the next tranche of its buyback program on 26 February 2026, for a total consideration of up to € 75 million. It is intended that, subject to market conditions, this tranche will be completed prior to the release of the Q3 trading update, scheduled for 27 November 2026. During this period, Bekaert will regularly publish press releases with updates on the progress made, as required by law. This information will also be available...
Bekaert kondigt de volgende tranche aan van het inkoopprogramma van ei...
Bekaert kondigt de volgende tranche aan van het inkoopprogramma van eigen aandelen Bekaert kondigt de volgende tranche aan van het inkoopprogramma van eigen aandelen Bekaert kondigt aan dat het op 26 februari 2026 zal beginnen met de volgende tranche van het inkoopprogramma van eigen aandelen, voor een totaalbedrag van maximaal € 75 miljoen. Het is de bedoeling dat, afhankelijk van de marktomstandigheden, deze tranche zal worden voltooid voor de publicatie van de Q3 activiteitenverslag op 27 november 2026. Tijdens deze periode, zal Bekaert regelmatig persberichten publiceren met updates ...
Bekaert: 2025 Full Year Results
Bekaert: 2025 Full Year Results 2025 Full year results Resilient results and strong cash flow supported by cost management and restructuring FCF1 of €314m n Proposed dividend of €1.95 n Ongoing €200m share buyback Bekaert delivered a resilient performance in 2025. The year was marked by shifts in global trade policies which created uncertainty and undermined demand. In addition, slower growth in the hydrogen end market required adjustment to bring footprint in line with demand outlook. At the same time, Bekaert has translated robust demand from investments in power and data transmission ...
Bekaert: Jaarresultaten 2025
Bekaert: Jaarresultaten 2025 Jaarresultaten 2025 Veerkrachtige resultaten en sterke kasstroom ondersteund door kostenbeheer en herstructurering FCF1 van €314m n Voorgesteld dividend van €1,95 n Lopend aandeleninkoopprogramma ter waarde van €200m Bekaert leverde een veerkrachtige prestatie in 2025. Het jaar werd gekenmerkt door verschuivingen in het wereldwijd handelsbeleid die voor onzekerheid zorgden en de vraag ondermijnden. Daarnaast moest de productievoetafdruk worden aangepast aan de vraagvooruitzichten vanwege de tragere groei van de eindmarkt voor waterstof. Tegelijkertijd heeft B...
- David Vagman
- CFA
- Maxime Stranart
Lotus Bakeries/Entering an era of increased profitability/BUY
We reiterate our BUY rating on Lotus Bakeries and increase our target price from €11,100 to €12,700 following the group stronger-than-expected FY25 results. We, however, remove Lotus Bakeries from the ING Benelux Favourite list, following its strong share price performance since the turn of the year. We upgrade our Normalised EPS by 2-3% respectively over 2026-29F, reflecting a stronger-than-expected benefit of the discontinuation of the ice cream business, as demonstrated by the group's 2H25 Ad...
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 12 February 2026 to 18 February 2026 Share Buyback ProgramOn , Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 25 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 12 February 2026 to 18 February 2026, Kepler Cheuvreux SA on behalf of Bekaert has bought 60 560 shares. Th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.